Nestlé three-month sales: 4.4% organic growth, full-year outlook confirmed
Provider: Nestlé Global Type: Link Title: Nestlé three-month sales: 4.4% organic growth, full-year outlook confirmed Description: In the first three months of 2015 organic growth was 4.4%, composed of 1.9% real internal growth and 2.5% pricing. Sales rose by 0.5% to CHF 20.9 billion, impacted by negative foreign exchange of -4.5%. Acquisitions, net of divestitures, added 0.6% to sales. Paul Bulcke, Nestlé CEO: "Our three-month sales growth was in line with expectations and driven by both real internal growth and pricing. We delivered good performances in Zone EMENA, Nestlé Waters and Other businesses. We continued our efforts to restore momentum in Zone AOA and in North America, and expect these initiatives to gain traction throughout the year. Our full-year outlook is confirmed: we aim to achieve organic growth of around 5% with improvements in margins, underlying earnings per share in constant currencies and capital efficiency." Read the press release. Watch the investor call audio webcast hosted by Steffen Kindler, Head of Investor Relations at 08:30 CET.
Nestlé nine-month sales: broad-based organic growth of 4.5% in a volatile environment
Provider: Nestlé Global Type: Link Title: Nestlé nine-month sales: broad-based organic growth of 4.5% in a volatile environment Description: In the first nine months of 2014, organic growth was 4.5%, composed of 2.3% real internal growth and 2.2% pricing. Sales were CHF 66.2 billion, impacted by substantial negative foreign exchange of -7.5%, and divestitures, net of acquisitions, further reduced sales growth by -0.1%. As a result the total evolution of sales was -3.1%. Paul Bulcke, Nestlé CEO: "In a volatile global trading environment where there are no tailwinds, we achieved good broad-based growth. While focusing on delivery today, we have taken decisions that reshape and strengthen our business for tomorrow. We have created ‘Nestlé Business Excellence’ to better leverage our scale and ensure that our markets can concentrate on growing their respective businesses. Despite the tough environment, in view of our year-to-date performance, we are still aiming for organic growth of around 5% for 2014 with improvements in margins, underlying earnings per share in constant currencies and capital efficiency." Read the press release. Watch the sales conference webcast hosted by Paul Bulcke, Chief Executive Officer and Wan Ling Martello, Nestlé Chief Financial Officer, live at 08:30 CET.
Nestlé acquires rights to aesthetic dermatology products in the US and Canada
Provider: Nestlé Global Type: Link Title: Nestlé acquires rights to aesthetic dermatology products in the US and Canada Description: As a result of the successful conclusion of the regulatory process and customary closing conditions, Nestlé today completed its acquisition of Valeant Pharmaceuticals International’s commercialisation rights to several key injectable aesthetic dermatology products in the US and Canada, as announced on 28 May 2014. These rights will be integrated into Nestlé Skin Health and commercialised by Galderma. Read the press release.
Nestlé acquisition of L’Oréal’s 50% stake in Galderma completed
Provider: Nestlé Global Type: Link Title: Nestlé acquisition of L’Oréal’s 50% stake in Galderma completed Description: As a result of the successful conclusion of the regulatory process and customary closing conditions, Nestlé today completed its acquisition of L’Oréal’s 50% stake in Galderma, as originally announced on 11 February 2014. Galderma, with approximately 5,000 employees and a presence in 80 countries, will henceforth operate as the pharmaceutical arm of Nestlé Skin Health S.A. Read the press release.
